Call:+1 7755157689
April 19, 2025


Contact Us

June 7, 2020

Dramatic Improvement in Dyspnea in A Non-Small Cell Lung Cancer Patient, Following Administration of Anti-IL-6R

Currently in most Lung Cancer cases in which there is tumor progression, the molecular approach is to search for new mutations, usually utilizing circulating free DNA. There are however cases where a trauma, such as an operation, is followed by rapid tumor progression and the key for treatment in these cases, might be the search for abnormal Cytokine levels.

Dramatic Improvement in Dyspnea in A Non-Small Cell Lung Cancer Patient, Following Administration of Anti-IL-6R Read More »

You cannot copy content of this page